Tonix Pharmaceuticals Investor Presentation 2021

Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company developing innovative medicines for central nervous system and immunology conditions. The company operates a pipeline ranging from preclinical to mid-Phase 3 programs, utilizing various therapeutic modalities including small molecules, peptides, and recombinant proteins with multiple routes of administration.